Boric Acid

Boric Acid

SCHEMBL217449

Fc1c(F)c(F)c(-c2c(F)c(F)c(F)c(F)c2F)c(F)c1F.Fc1c(F)c(F)c(-c2c(F)c(F)c(F)c(F)c2F)c(F)c1F.Fc1c(F)c(F)c(-c2c(F)c(F)c(F)c(F)c2F)c(F)c1F.Fc1c(F)c(F)c(-c2c(F)c(F)c(F)c(F)c2F)c(F)c1F.OB(O)O

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Boric Acid SCHEMBL6277854 1.00 LMNA (0.33) LMNATSHRTDP1
Boric Acid SCHEMBL5074757 1.00 LMNA (0.33) LMNATSHRTDP1
Boric Acid SCHEMBL14861821 0.96 LMNA (0.31) LMNATSHRTDP1
Benzene SCHEMBL28373023 0.89 CA4 (0.32)
Trimethylammonium SCHEMBL217135 0.87
Tert-Butylamine SCHEMBL3935873 0.84 GGT1 (0.30)
Boric Acid SCHEMBL14841786 0.82
Boric Acid SCHEMBL17857654 0.82
SCHEMBL14157108 0.82
SCHEMBL7174935 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1606 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110834-B1 ANSA-BIS(INDEN-2-YL) CATALYSTS FOR PRODUCING VINYLIDENE-TERMINATED POLYALPHAOLEFINS EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-04-03 EP claimed
CN-114269798-B High propylene content EP with low glass transition temperature 埃克森美孚化学专利公司 2024-02-27 CN claimed
CN-113614123-B Transition metal bis (phenoxide) complexes and their use as olefin polymerization catalysts 埃克森美孚化学专利公司 2024-01-23 CN claimed
CN-112513110-B Ethylene-propylene linear copolymers as viscosity modifiers 埃克森美孚化学专利公司 2023-10-27 CN claimed
US-11760814-B2 1,5 diazabicyclooctane ligand systems and methods therewith EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-09-19 US claimed
US-11739169-B2 Solubility improvement of non-metallocene transition metal complexes in aliphatic hydrocarbon solvents EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-08-29 US claimed
EP-4222180-A1 BIS(HETEROCYCLIC-OLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF ExxonMobil Chemical Patents Inc. (US) 2023-08-09 EP claimed
CN-116323694-A Bis (heterocyclic-alkoxide) lewis base catalysts and methods thereof 埃克森美孚化学专利公司 2023-06-23 CN claimed
EP-4196507-A1 CYCLIC CONTAINING POLYMER COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND PROCESS FOR PRODUCTION THEREOF ExxonMobil Chemical Patents Inc. (US) 2023-06-21 EP claimed
CN-112004841-B Process for preparing high propylene content PEDM with low glass transition temperature using tetrahydroindacene based catalyst system 埃克森美孚化学专利公司 2023-05-26 CN claimed
EP-1183280-B1 CATALYST AND PROCESS FOR PREPARING OLIGOMERS OF ALPHA-METHYL STYRENE GOODRICH CORP (US) 2005-03-23 EP claimed
US-20040266961-A1 Catalyst composition II EXXONMOBIL CHEMICAL PATENTS INC. 2004-12-30 US claimed
WO-2004106390-A2 POLYMERIZATION AND OLIGOMERIZATION CATALYST WITH TRIDENTATE OR TETRADENTATE LIGAND EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-12-09 WO claimed
WO-2004026923-A9 SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM EXXONMOBIL CHEM PATENTS INC (US) 2004-09-10 WO claimed
US-20040122191-A1 Supercritical polymerization process and polymers produced therefrom EXXONMOBIL CHEMICAL PATENTS INC 2004-06-24 US claimed
WO-2004026923-A2 SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-04-01 WO claimed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO claimed
US-6441260-B1 Catalyst and process for preparing oligomers of α-methylstyrene THE B.F. GOODRICH COMPANY 2002-08-27 US claimed
EP-1183280-A1 CATALYST AND PROCESS FOR PREPARING OLIGOMERS OF ALPHA-METHYL STYRENE The B.F. Goodrich Company (US) 2002-03-06 EP claimed
WO-2000075199-A1 CATALYST AND PROCESS FOR PREPARING OLIGOMERS OF ALPHA-METHYL STYRENE THE B.F. GOODRICH COMPANY (US) 2000-12-14 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760814-B2 1,5 diazabicyclooctane ligand systems and methods therewith ODC1, DDT, OXGR1 LMNA 3250/4885TSHR 4711/4885TDP1 861/4885
US-20040266961-A1 Catalyst composition II MLX, CBX2, BMX LMNA 25/4885TSHR 4496/4885TDP1 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.